Skip to main content
Premium Trial:

Request an Annual Quote

EpiCypher Licenses Chromatin Profiling Technologies From Fred Hutchinson Cancer Center

NEW YORK — EpiCypher said on Wednesday that it has acquired a co-exclusive license to the CUT&RUN (Cleavage Under Targets and Release Using Nuclease) and CUT&Tag chromatin profiling technologies from the Fred Hutchinson Cancer Research Center.

Financial terms of the agreement were not disclosed.

According to EpiCypher, CUT&RUN and CUT&Tag use protein A and protein G to tether enzymatic domains to antibody-bound chromatin in immobilized cells or nuclei for controlled and site-selective cleavage in situ. Used to study histone post-translational modifications and chromatin-associated proteins as an alternative to ChIP-seq, the two approaches require tenfold fewer sequencing reads and can accommodate ultra-low cellular inputs, including single-cell analyses, the company said.

EpiCypher said the new license builds on its existing intellectual property portfolio covering CUT&RUN and CUT&Tag workflows for both research-use-only and diagnostic applications. The Research Triangle Park, North Carolina-based company added that it intends to expand its portfolio of CUT&RUN and CUT&Tag products, which are sold under its Cutana brand.

"EpiCypher's Cutana platform is changing the way researchers approach genomic mapping studies, especially for drug development," EpiCypher CSO Michael-Christopher Keogh said in a statement. "This foundational IP gives us the support to build next-generation assays that further improve assay sensitivity, throughput, and cost."

The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.